Fig. 4.
Percentage of subjects with onset of a new treatment-related adverse event (AE) (the most frequent [≥5%] treatment-related AEs), during each week of the first year of treatment with the SQ HDM SLIT-tablet (pooled data from MT-04 and MT-06).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.